Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
768,300
-
Total 13F shares
-
51,941
-
Share change
-
+51,852
-
Total reported value
-
$113,749
-
Price per share
-
$2.19
-
Number of holders
-
10
-
Value change
-
+$113,554
-
Number of buys
-
9
Institutional Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q4 2023
As of 31 Dec 2023,
Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,941 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., GROUP ONE TRADING, L.P., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., WELLS FARGO & COMPANY/MN, MORGAN STANLEY, UBS Group AG, and BARTLETT & CO. WEALTH MANAGEMENT LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.